Expanding the scope of Bioactive Molecules and Pharmaceuticals
DOI :
https://doi.org/10.31989/bmp.v3i2.1948Résumé
The launch of Bioactive Molecules and Pharmaceuticals in 2023 marked the introduction of a specialized academic platform dedicated to the rapidly advancing interface between molecular bioactivity and pharmaceutical science. The purpose of the journal was to be a venue across disciplines in order to bridge biochemical research, translational biomedical science, and therapeutic innovations.
Téléchargements
Publié
Numéro
Rubrique
Licence
© BMP/Bioactive Molecules and Pharmaceuticals 2026
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale 4.0 International.
Any manuscripts or substantial parts of it, submitted to the journal must not be under consideration by or previously published in any other journal or citable form. Authors are required to ensure that no material submitted as part of a manuscript infringes existing copyrights or the rights of a third party. In submitting one's article in any form, the author has assigned the FFC publishing rights and has agreed to an automatic transfer of the copyright to the publisher. This is so that the FFC may create print option journals, for example, at the FFC’s discretion. If the author wishes to distribute their works by means outside of the FFC, for example within their community, they will have to place a request.
Correspondence concerning articles published in Functional Foods in Health and Disease is encouraged. While derivative works (adaptations, extensions on the current work, etc.) are allowed, distribution of the modified material is not allowed without permission from the FFC.
